Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0791-2025

Medline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LF Recall

Medline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LF

FDA recall Class II

Ongoing

FDA lists this Class II recall for Medline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LF. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0791-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 21, 2024
FDA report date
Jan 8, 2025
Quantity in commerce
128 units
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Medline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LF

Affected model & UDI checker

Search the exact identifiers published for Z-0791-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedMedline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LFCheck source notice10889942825547
Not specifiedMedline custom medical procedure kits labeled as: DEEP BRAIN STIMULATION PACK-LFCheck source notice40889942825548
FDA code information

UDI/DI 10889942825547 (EA) 40889942825548 (CS), Lot Numbers: 19BKB326, 19DKA892, 19JDA775, 20ADC560

View the original FDA recall notice

Why was this product recalled?

Custom convenience kits are being recall because the contain non-sterile Codman Surgical Patties & Surgical Strips, which have the potential for endotoxin contamination.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did MEDLINE INDUSTRIES, LP - Northfield take?

Medline issued a MEDICAL DEVICE VOLUNTARY RECALL notice on 11/21/2024 to its consignees via US Mail and email. The notice explained the issue, potential risk to health, and requested that the affected product be quarantined. Once the response is received, Medline will provide labels to place on affected inventory, with instructions for the consignee to remove the affected component prior to using the kit.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology